Signet Financial Management, Llc
Source: SEC Form 13F · as of Mar 2026Signet Financial Management, Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $39.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$39.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 10,249 | $9.4M |
| UTHRUNITED THERAPEUTICS Corp | 10,781 | $6.4M |
| ABBVAbbVie Inc. | 24,722 | $5.4M |
| MCKMcKesson Corporation | 4,048 | $3.5M |
| JNJJOHNSON & JOHNSON | 13,724 | $3.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,895 | $3.0M |
| AZNASTRAZENECA PLC | 13,656 | $2.7M |
| AMGNAMGEN INC | 6,053 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 11,892 | $721K |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | 28,895 | $652K |
| MRKMerck & Co., Inc. | 4,066 | $489K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,363 | $462K |
| ABTABBOTT LABORATORIES | 2,965 | $304K |
| PMPhilip Morris International Inc | 1,633 | $270K |
| PFEPFIZER INC | 8,800 | $247K |
| ELVElevance Health Inc. | 837 | $245K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.